Presight Capital
Presight Capital is a venture capital firm investing in the most ambitious founders across sectors, stages, and geographies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Presight Capital Information
Geographic Data
Address: -
City: New York
State: NY
Zip: 10282
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$430M
Social
Linkedin
Crunchbase
Metrics
5,516,416Website Global Rank
1,691Website Monthly Traffic
Twitter Followers
Description
Presight Capital is a venture capital firm investing in the most ambitious founders across sectors, stages, and geographies. Presight takes a global approach to early-stage investment opportunities in software, frontier technologies &a; biotech, backed by Apeiron, the family office of Christian Angermayer, and a group of world-class investors: Moore Capital, Point72, Mike Novogratz (former CIO of Fortress Investment Group), Martin Chavez (former CFO of Goldman Sachs), Alan Howard (Brevan Howard), Brent Hoberman (Founders Forum), and many successful entrepreneurs and investors who contribute their respective network and experience.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2020 | Razor Group | Venture Round | 4.2M |
| 12/2021 | thirdweb | Seed Round | 5M |
| 10/2022 | Hoxton Farms | Series A | 0 |
| 12/2019 | Starship | Series A | 7M |
| 5/2022 | Bamba | Seed | 3.2M |
| 2/2021 | Penta | Series B | 0 |
| 1/2022 | Denario | Seed Round | 2M |
| 12/2020 | Peptilogics | Series B | 35.4M |
| 4/2021 | Alloy Therapeutics | Series C | 75M |
| 3/2020 | AbCellera Biologics | Series A | 75M |
| 12/2020 | Rational Vaccines | Series A | 10M |
| 5/2020 | AbCellera | Series B | 105M |
| 2/2021 | Hoxton Farms | Seed Round | 0 |
| 2/2022 | FORME | Series A | - |
| 3/2021 | Velocity | Seed Round | 10.3M |
| 2/2021 | Valoreo | Seed Round | 50M |
| 6/2019 | Deciduous Therapeutics | Seed Round | 6.5M |
| 5/2021 | Una Brands | Debt Financing | - |
| 7/2022 | Lilo | Pre Seed Round | 0 |
| 2/2020 | Unmind | Series A | 10M |
| 12/2022 | Razor Group | Private Equity Round | 70M |
| 9/2020 | Syfe | Series A | 18.6M |
| 5/2021 | Razor Group | Venture Round | 25M |
| 10/2020 | Angiex | Venture Round | 2M |
| 4/2021 | Angiex | Series B | 25M |
| 11/2021 | Blackrock Neurotech | Convertible Note | - |
| 9/2021 | Delix Therapeutics | Series A | 0 |
| 7/2021 | Syfe | Series B | 0 |
| 6/2020 | Fortu | Seed | 5M |
| 5/2022 | Bamba | Seed Round | 3.2M |
| 7/2021 | TMRW Life Sciences | Series C | 105M |
| 11/2021 | Divibank | Seed Round | 5.2M |
| 10/2021 | Grounded Foods Co. | Seed Round | 0 |
| 5/2021 | Blackrock Neurotech | Private Equity Round | 0 |
| 3/2022 | Alaan | Seed Round | 0 |
| 8/2021 | UpScalio | Series A | 0 |
| 1/2021 | New Amsterdam Pharma | Series A | 0 |
| 12/2019 | General Fusion | Series E | 0 |
| 6/2020 | Alloy Therapeutics | Series B | 11.3M |
| 12/2022 | Razor Group | Series C | 0 |
| 4/2022 | Mueshi | Seed Round | 0 |
| 12/2021 | Koniku | Series A | 0 |
| 9/2020 | Delix Therapeutics | Seed Round | 8M |
| 11/2021 | Bound | Seed Round | 0 |
| 3/2021 | ATAI Life Sciences | Series D | 0 |
| 2/2022 | Valoreo | Series B | 80M |
| 4/2023 | Razor Group | Series C | 0 |
| 2/2020 | EnClear Therapies | Series A | 0 |
| 3/2019 | EnClear Therapies | Seed Round | 2M |
| 10/2022 | Alloy Therapeutics | Series D | 42M |
| 11/2021 | Parker | Series A | - |
| 4/2021 | Parker | Seed Round | - |
| 4/2022 | Earth | Seed Round | 0 |
| 12/2019 | Chemomab | Series C | 20M |
| 3/2021 | Chemomab | Post-IPO Equity | 45.5M |
| 2/2022 | Cloud Paper | Equity | 5M |
| 11/2021 | Peek | Series C | 0 |
| 6/2021 | Umoja Biopharma | Series B | 0 |
| 10/2022 | Alto Neuroscience | Series B | 35M |
| 5/2021 | Alto Neuroscience | Series A | 0 |
| 1/2021 | Sensei Biotherapeutics | Series B | 0 |
| 3/2022 | Rejuveron Life Sciences | Series B | - |
| 7/2020 | Penta | Series B | 4.5M |
| 10/2020 | Sensei Biotherapeutics | Series A | 0 |
| 9/2020 | Cloud Paper | Seed Round | 3M |
| 8/2021 | Penta | Series B | 0 |
| 4/2022 | RARIO | Series A | 0 |
| 1/2022 | Nana Delivery | Pre-Seed | 3.6M |
| 10/2022 | Joro | Series A | 10M |
| 1/2023 | Alaan | Seed Round | 4.5M |
| 11/2021 | Razor Group | Series B | 125M |
| 7/2021 | Valoreo | Series A | 30M |
| 5/2021 | Una Brands | Seed Round | 40M |
| 11/2021 | Velocity | Series A | 20M |
| 6/2021 | UpScalio | Seed Round | 5M |
| 4/2022 | Enable Medicine | Series A | 60M |
| 11/2021 | Una Brands | Series A | 15M |
| 9/2021 | Perfect Day | Series D | 0 |
| 7/2022 | Cleerly | Series C | 0 |
| 9/2019 | Karma Biotechnologies | Seed Round | 2.1M |
| 11/2021 | Lindus Health | Seed Round | 5M |
| 6/2021 | Opontia | Seed Round | - |
| 6/2021 | Opontia | Debt Financing | 20M |
| 11/2020 | Razor Group | Venture Round | 11.8M |
| 7/2022 | Cleerly | Series C | 0 |
| 7/2022 | Lilo | Pre Seed Round | 0 |
| 5/2022 | Bamba | Seed Round | 0 |
| 4/2022 | RARIO | Series A | 0 |
| 3/2022 | Alaan | Seed Round | 0 |
| 2/2022 | Cloud Paper | Venture Round | 0 |
| 1/2022 | Nana Delivery | Pre Seed Round | 0 |
| 1/2022 | Denario | Seed Round | 0 |
| 12/2021 | Koniku | Series A | 0 |
| 12/2021 | thirdweb | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
